Approvals/TGA/IRBESARTAN HCT MYLAN 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle

Approved

STANDARD

IRBESARTAN HCT MYLAN 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle

Alphapharm Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: dfeecd2e647fbe96
Product Name: IRBESARTAN HCT MYLAN 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle
Artg Id: 215945
Artg Name: IRBESARTAN HCT MYLAN 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle
Sponsor: Alphapharm Pty Ltd
Company Detail Path: /organization/alphapharm-pty-ltd
Artg Date: 2013-11-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

dfeecd2e647fbe96

Type

Standard